silver has been researched along with Chronic Lung Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, W; Li, M; Li, P; Su, W; Wang, Y; Wu, H; Zhang, J; Zhang, X | 1 |
| Alodhayani, AA; Alotaibi, BS; Altwaijry, N; El-Masry, TA; El-Morshedy, K; Elmaghed, NA; Saleh, A; Sayed, AE; Tousson, E | 1 |
2 other study(ies) available for silver and Chronic Lung Injury
| Article | Year |
|---|---|
Naringenin attenuates inflammation, apoptosis, and ferroptosis in silver nanoparticle-induced lung injury through a mechanism associated with Nrf2/HO-1 axis: In vitro and in vivo studies.
Topics: Animals; Anti-Inflammatory Agents; Heme Oxygenase-1; Humans; Inflammation; Lung Injury; Metal Nanoparticles; Mice; Mice, Inbred ICR; NF-E2-Related Factor 2; Oxidative Stress; Silver | 2022 |
Potential therapeutic effects of avenanthramide-C against lung toxicity caused by silver nanoparticles injection in rats.
Topics: Animals; Blood Cells; Cyclooxygenase 2; Erythrocyte Count; Hematocrit; Hemoglobins; Leukocyte Count; Lung; Lung Injury; Metal Nanoparticles; ortho-Aminobenzoates; Platelet Count; Rats; Silver; Tumor Necrosis Factor-alpha | 2021 |